These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

758 related articles for article (PubMed ID: 16157901)

  • 1. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of LRRK2, SNCA, Parkin, PINK1, and DJ-1 in Zambian patients with Parkinson's disease.
    Yonova-Doing E; Atadzhanov M; Quadri M; Kelly P; Shawa N; Musonda ST; Simons EJ; Breedveld GJ; Oostra BA; Bonifati V
    Parkinsonism Relat Disord; 2012 Jun; 18(5):567-71. PubMed ID: 22445250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease: is there a gender effect?
    Orr-Urtreger A; Shifrin C; Rozovski U; Rosner S; Bercovich D; Gurevich T; Yagev-More H; Bar-Shira A; Giladi N
    Neurology; 2007 Oct; 69(16):1595-602. PubMed ID: 17938369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
    Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A
    Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of LRRK2 mutations and Parkinson's disease in Brazil.
    Pimentel MM; Moura KC; Abdalla CB; Pereira JS; de Rosso AL; Nicaretta DH; Campos M; de Almeida RM; dos Santos JM; Bastos IC; Mendes MF; Maultasch H; Costa FH; Werneck AL; Santos-Rebouças CB
    Neurosci Lett; 2008 Mar; 433(1):17-21. PubMed ID: 18201824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.
    Gaig C; Ezquerra M; Marti MJ; Muñoz E; Valldeoriola F; Tolosa E
    Arch Neurol; 2006 Mar; 63(3):377-82. PubMed ID: 16533964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low frequency of common LRRK2 mutations in Mexican patients with Parkinson's disease.
    Yescas P; López M; Monroy N; Boll MC; Rodríguez-Violante M; Rodríguez U; Ochoa A; Alonso ME
    Neurosci Lett; 2010 Nov; 485(2):79-82. PubMed ID: 20727385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease.
    Choi JM; Woo MS; Ma HI; Kang SY; Sung YH; Yong SW; Chung SJ; Kim JS; Shin HW; Lyoo CH; Lee PH; Baik JS; Kim SJ; Park MY; Sohn YH; Kim JH; Kim JW; Lee MS; Lee MC; Kim DH; Kim YJ
    Neurogenetics; 2008 Oct; 9(4):263-9. PubMed ID: 18704525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: importance of G2019S and R1441C mutations in sporadic Parkinson's disease patients.
    Floris G; Cannas A; Solla P; Murru MR; Tranquilli S; Corongiu D; Rolesu M; Cuccu S; Sardu C; Marrosu F; Marrosu MG
    Parkinsonism Relat Disord; 2009 May; 15(4):277-80. PubMed ID: 18805725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LRRK2 mutations in Parkinson disease.
    Farrer M; Stone J; Mata IF; Lincoln S; Kachergus J; Hulihan M; Strain KJ; Maraganore DM
    Neurology; 2005 Sep; 65(5):738-40. PubMed ID: 16157908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
    Lesage S; Janin S; Lohmann E; Leutenegger AL; Leclere L; Viallet F; Pollak P; Durif F; Thobois S; Layet V; Vidailhet M; Agid Y; Dürr A; Brice A; ; Bonnet AM; Borg M; Broussolle E; Damier P; Destée A; Martinez M; Penet C; Rasco O; Tison F; Tranchan C; Vérin M
    Arch Neurol; 2007 Mar; 64(3):425-30. PubMed ID: 17353388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease and LRRK2: frequency of a common mutation in U.S. movement disorder clinics.
    Kay DM; Zabetian CP; Factor SA; Nutt JG; Samii A; Griffith A; Bird TD; Kramer P; Higgins DS; Payami H
    Mov Disord; 2006 Apr; 21(4):519-23. PubMed ID: 16250030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive LRRK2 and GBA screening in Portuguese patients with Parkinson's disease: identification of a new family with the LRRK2 p.Arg1441His mutation and novel missense variants.
    Zhang L; Quadri M; Guedes LC; Coelho M; Valadas A; Mestre T; Lobo PP; Rosa MM; Simons E; Oostra BA; Ferreira JJ; Bonifati V
    Parkinsonism Relat Disord; 2013 Oct; 19(10):897-900. PubMed ID: 23726462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic factors influencing age at onset in LRRK2-linked Parkinson disease.
    Golub Y; Berg D; Calne DB; Pfeiffer RF; Uitti RJ; Stoessl AJ; Wszolek ZK; Farrer MJ; Mueller JC; Gasser T; Fuchs J
    Parkinsonism Relat Disord; 2009 Aug; 15(7):539-41. PubMed ID: 19041274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive screening of a North American Parkinson's disease cohort for LRRK2 mutation.
    Johnson J; Paisán-Ruíz C; Lopez G; Crews C; Britton A; Malkani R; Evans EW; McInerney-Leo A; Jain S; Nussbaum RL; Foote KD; Mandel RJ; Crawley A; Reimsnider S; Fernandez HH; Okun MS; Gwinn-Hardy K; Singleton AB
    Neurodegener Dis; 2007; 4(5):386-91. PubMed ID: 17622782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.